ECIFX
Price
$13.05
Change
+$0.01 (+0.08%)
Updated
Dec 3 closing price
Net Assets
1.1B
RLBEX
Price
$39.67
Change
+$0.07 (+0.18%)
Updated
Dec 2 closing price
Net Assets
271.11B
Interact to see
Advertisement

ECIFX vs RLBEX

Header iconECIFX vs RLBEX Comparison
Open Charts ECIFX vs RLBEXBanner chart's image
Eaton Vance Balanced C
Price$13.05
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets1.1B
American Funds American Balanced R4
Price$39.67
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets271.11B
ECIFX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
ECIFX vs. RLBEX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECIFX is a StrongBuy and RLBEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 271B vs. ECIFX (1.1B). RLBEX pays higher dividends than ECIFX: RLBEX (1.68) vs ECIFX (0.43). ECIFX was incepted earlier than RLBEX: ECIFX (32 years) vs RLBEX (23 years). ECIFX (1.72) is less costly to investors than RLBEX (0.59). RLBEX is a more actively managed with annual turnover of: 44.00 vs. ECIFX (5.00). RLBEX has a lower initial minimum investment than ECIFX: RLBEX (250) vs ECIFX (1000). RLBEX annual gain was more profitable for investors over the last year : 9.28 vs. ECIFX (3.50). RLBEX return over 5 years is better than : 39.06 vs. ECIFX (23.05).
ECIFXRLBEXECIFX / RLBEX
Total Expense Ratio1.720.59292%
Annual Report Gross Expense Ratio1.720.59292%
Fund Existence32 years23 years-
Gain YTD10.27316.57462%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B271B0%
Annual Yield % from dividends0.431.6826%
Returns for 1 year3.509.2838%
Returns for 3 years32.2340.1980%
Returns for 5 years23.0539.0659%
Returns for 10 years60.2376.6779%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX82.321.55
+1.92%
Inhibrx Biosciences Inc.
BMO125.741.57
+1.26%
Bank of Montreal
LIVE9.81-0.04
-0.41%
Live Ventures
PIPR323.49-5.45
-1.66%
Piper Sandler Companies
ARMP5.53-1.23
-18.24%
Armata Pharmaceuticals